Rate My Professor Michael Kohn

Western Sydney University

4.5

2 reviews · out of 5

Rate Michael

Is this you? Claim this profile

Ratings & reviews

4.05/21/2025

Always goes the extra mile for students.

5.04/30/2025

This comment is not public.

Taught by or worked with Michael?

Add your rating. It takes about 30 seconds.

About Michael

Professor Michael Kohn is the Chair in Paediatrics and Child Health and Professor of Paediatrics and Child Health in the School of Medicine at Western Sydney University. He holds the qualifications MBBS, FRACP, FACPM, and PhD. As a developmental paediatrician, he possesses over 30 years of experience in the assessment and management of conditions impacting the health and development of children, adolescents, and young adults. His academic career at Western Sydney University encompasses extensive research activity from 1996 to 2025, resulting in 157 research outputs, including 132 articles, 15 review articles, 4 comments/debates, and 3 chapters. These contributions have achieved an h-index of 44 and over 5,900 citations.

Professor Kohn's research specializations center on paediatric and adolescent health issues, particularly eating disorders such as anorexia nervosa, bulimia nervosa, restrictive eating disorders, and binge eating disorder. His work examines nutritional rehabilitation, long-term bone outcomes in adolescent anorexia nervosa, neural responses to low- and high-energy foods in bulimia nervosa, changes in estimated glomerular filtration rate during inpatient treatment, arterial stiffness during weight restoration, and psychiatric and medical comorbidities. Additional research interests include attention-deficit/hyperactivity disorder (ADHD) subtypes defined by cognition, their neural and clinical profiles, response inhibition and emotional cognition improved by atomoxetine, core ADHD symptom improvement comparing atomoxetine and methylphenidate via meta-analysis, and functional connectivity mechanisms underlying symptom reduction. He has also published on the worldwide epidemic of obesity in adolescents, subacute combined degeneration in adolescents with anorexia nervosa, fluoxetine for autistic behaviors, healthcare transition self-efficacy, chronic vomiting cases, and the impact of policy levers on mental health service use in eating disorders. Notable publications include 'Psychiatric and medical comorbidities of eating disorders: finding the missing "missing third"' (2022), 'Core ADHD symptom improvement with atomoxetine versus methylphenidate: A direct comparison meta-analysis' (2011), 'Attention-deficit/hyperactivity disorder subtypes defined by cognition have a distinct neural and clinical profile and differ in response to atomoxetine' (2025), 'Changes in eGFR in adolescent and young adult inpatients receiving nutritional rehabilitation for a restrictive eating disorder: a five-year clinical audit' (2025), and 'A pilot prospective study of arterial stiffness during weight restoration in adolescents with anorexia nervosa' (2025). Professor Kohn is affiliated with the Translational Health Research Institute at Western Sydney University.